Table 2.

aCGH results

ID	aCGH testing interval (days)	DNA input quantity (ng)	DNA260/280	DNA conc (Qubit) ng/ul	DLRS	Sufficiency	aCGH results	aCGH interpretation
1	13	1000	1.97	161	0.3	HR	arr (1-22,X) x2	Euploid female
2	12	1000	1.92	85	0.42	HR	arr (1-22,X) x2, gain 70Kb at 1q42.13, loss 230Kb at 3q27.2	Female with unclassified CNV
3	15	500	2.02	28.6	0.47	LR	arr (1-22,X) x2	Euploid female
4	13	250	2.03	10.4	0.45	LR	arr (1-22,X) x2	Euploid female
5	15	1000	1.99	83	0.67	HR	arr (1-22,X)x2, gain 660Kb at 5q13.1, gain 330Kb at 5q32	Female with unclassified CNV
6	13	550	1.91	23	0.33	HR	arr mos 7p11.2-q11.23 (55,824,493-75,930,688) x1	Male with mosaic deletion including Williams syndrome chromosome region
7	35	800	2.01	47.8	0.28	HR	arr (1-22) x2, (XY) x1	Euploid male
8	14	1000	21.93	446	0.28	HR	arr (1-22,X) x2	Euploid female
9	2					I	-	Insufficient fetal tissue
10	2					I	-	Insufficient fetal tissue
11	9	220	1.98	26.6	0.71	LR	arr (1-12,14-22) x2, mos (13) x3, mos (X) x2, mos (Y) x1	MCC in T13 male v. vanished T13 female twin v. chimeric pregnancy v. true mosaic
12	9	460	1.62	14.9	0.7	LR	arr (1-20,22,X) x2 (21) x3	Female with Trisomy 21
13	47	1000	1.9	154	0.26	HR	arr (1-22,X) x2	Euploid female
14	27	600	2.01	41.8	0.4	LR	arr (1-22,X) x2	Euploid female
15	40	1000	1.91	92	0.34	HR	arr18p11.32q23 (1-78847598)x3;	Female with Trisomy 18
16	37	1000	2.05	94.2	0.32	HR	arr (1-22, X) x2	Euploid female
17	41	300	1.9	15.7	0.31	HR	arr 11p11.32q23 (1-135006515)x3	Male with Trisomy 11
18	30		1.99	56.4		I	-	Insufficient fetal tissue
19	1					I	-	Insufficient fetal tissue
20	50	750	1.88	48.4	0.44	HR	arr4p16.3p15.2 (230836-27342422) x1, arr5q33.2q35.3 (154280916-180674029) x3	Male with unbalanced 4p-5q translocation; known paternal paracentric inversion

Abbreviations:DLRS Distribution of Log2 Ratio Spread, CNV copy number variant, HR high-resolution, LR low-resolution, I insufficient, MCC maternal cell contamination, T13 Trisomy 13.